Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Modernising haematological malignancy adverse event assessment and reporting Lan-Lan Smith, Gita Thanarajasingam Targeted agents, immune and cellular therapies and other novel agents have led to dramatic shifts in the treatment of many hematologic malignancies (H... 5 months ago | 63 mins Sepsis Overview: Challenges and Solutions for Laboratories Mirta Gamez, M.T.(A.S.C.P.), C.L.S. Sepsis presents a global healthcare crisis, with more people dying from sepsis than from prostate cancer, colon cancer, breast cancer and AIDS combine... 3 years ago | 51 mins Innovations in Multivariate Hematology Analysis Gert-Jan van de Geijn, Ph.D. In this on-demand webinar, Dr. Gert-Jan van de Geijn, renowned hematology expert, researcher and industry leader, discusses new chronic obstructive pu... 5 years ago | 51 mins 2D Ex Vivo Patient-derived AML Platform for testing Molecular-Targeted Therapies Bandana Vishwakarma, PhD, Scientist in Hematology Oncology at Champions Oncology Champions Oncology was excited to participate in the American Association of Cancer Research’s (AACR) Virtual Meeting in June. Due the limited availab... 3 years ago | 22 mins Quality Assurance Procedures to Minimize the Lab's Spurious Results Ahmed Bentahar MD, PhD, Senior Manager Global Scientific Marketing, Hematology/Urinalysis, Beckman Coulter When errors pass through laboratory tests undetected, patients may suffer. What if one of the tests your laboratory performs frequently is also the on... 5 years ago | 64 mins Establishment of a Patient-derived B-ALL Ex Vivo Platform Bandana Vishwakarma, PhD, Scientist in Hematology Oncology at Champions Oncology Champions Oncology was excited to participate in the American Association of Cancer Research’s (AACR) Virtual Meeting in June. Due the limited availab... 2 years ago | 23 mins Advanced Hematology Oncology PDX Tumor Biology Platforms for Drug Advancement Neal Goodwin, PhD, Vice President of Research Development Champions Oncology has established an advanced PDX platform for modeling hematology oncology malignancies, including AML and ALL. The resource consist... 3 years ago | 45 mins Lean High-volume Hematology Solutions Alan Neal, CSci, MSc, FIBMS, quality manager and lead of specialty, hematology, at Pathology Associates Alan Neal explains how Beckman Coulter’s Lean high-volume hematology solutions can improve laboratory efficiency and help deliver better patient care.... 7 years ago | 65 mins Principles Of CAR T-Cell Therapy And The Pathway To Regulatory Approval Brian Marks and Ashley Jones For many years, the primary forms of cancer treatment have been chemotherapy, radiation and surgery, but the toughest forms of cancer demand breakthro... 2 years ago | 36 mins Using Hematology Assays to Assess Sepsis Risk Jeannine Holden, M.D., MBA . 3 years ago | 29 mins Load more
